Expedition 74 crew members aboard the International Space Station are manufacturing large quantities of stem cells to advance cancer research and other disease treatments. Microgravity conditions on the station allow certain biological processes to proceed differently than on Earth, enabling production of stem cell cultures that researchers cannot easily replicate in ground laboratories.
Stem cells hold promise for regenerative medicine because they can differentiate into multiple cell types under controlled conditions. Space-based manufacturing aims to produce higher-quality or larger-volume cell batches for study by terrestrial research teams working on cancer therapies and tissue repair applications.
NASA and international partners have increasingly used the station as a platform for biomedical experiments that leverage the unique environment of low Earth orbit. Crew time and cargo capacity limit how much biological material can be produced during each expedition, but results from prior missions have encouraged expanded stem cell work.
Research teams on the ground will analyze stem cell samples returned from the station to assess whether space-manufactured cultures offer advantages for therapeutic development. The work forms part of a broader portfolio of space station research targeting health applications with potential benefits for patients on Earth.
Space station biomedical experiments require careful cold-chain handling when samples return to Earth for analysis in terrestrial laboratories equipped for advanced cell biology techniques. NASA publishes mission summaries and peer-reviewed results from prior station research that inform planning for expanded manufacturing campaigns during subsequent expedition increments.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.nasa.gov/international-space-station/space-station-research-and-technology/latest-news-from-space-station-research/